真实世界中MET 14外显子跳跃突变晚期非小细胞肺癌的疗效分析
王涵敏， 彭楷程， 苏俊威， 薛为哲， 杨衿记 - 循证医学, 2021 - jebm.cn
… MET exon 14 skipped locally advanced or metastatic non⁃small cell lung cancer(NSCLC)patients
who did not … targeted therapy for NSCLC with MET exon 14 skipping in this study were …
who did not … targeted therapy for NSCLC with MET exon 14 skipping in this study were …
非小细胞肺癌中MET 抑制剂的耐药机制及应对策略研究进展
韩森， 马旭， 方健 - 中国肿瘤临床, 2020 - cjco.cn
… small cell lung cancer (NSCLC). Drugs targeting tumor with MET exon 14 skipping mutations
… Although MET inhibitors such as tepotinib and savolitinib have shown good antitumor …
… Although MET inhibitors such as tepotinib and savolitinib have shown good antitumor …
[HTML][HTML] 文传商讯| 论文荟萃| 经验案例| 物流新闻| 环球气象| 企业黄页| 阔度财富
GBW DARMSTADT - global56.com
… ® (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
MET 靶点在非小细胞肺癌中的研究进展
张博， 金波 - 中华临床医师杂志(电子版), 2021 - zhlcyszz.cma-cmc.com.cn
… or hepatocyte growth factor (HGF) protein, MET gene amplification, MET gene mutation,
MET … treatment options for MET exon 14 skipping alterations in non-small cell lung cancer [J]. …
MET … treatment options for MET exon 14 skipping alterations in non-small cell lung cancer [J]. …
[HTML][HTML] 中国人物访谈网admin 2021-12-20 15: 14
GBW DARMSTADT - chinayskt.com
… ® (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
[HTML][HTML] 尚点资讯网-国际综合资讯平台admin 2021-12-20 15: 14
GBW DARMSTADT - shangdianzixun.com
… ® (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
cell lung cancer (… -epithelial transition factor gene exon 14 (METex14) skipping, who require …
非小细胞肺癌罕见靶点靶向治疗最新研究进展
李国雨， 何明 - 协和医学杂志, 2021 - xhyxzz.pumch.cn
… in the treatment of non-small cell lung cancer (NSCLC). … 观察savolitinib在MET exon 14
跳跃突变NSCLC 患者中的 … 项评估tepotinib 治疗未经 MET靶向治疗, MET exon14 跳跃突变…
跳跃突变NSCLC 患者中的 … 项评估tepotinib 治疗未经 MET靶向治疗, MET exon14 跳跃突变…
[引用][C] TEPMETKO (tepotinib) Receives Positive CHMP Opinion for Patients with Advanced NSCLC with METex14 Skipping Alterations 作者: CN-INFO 责任编辑: 文传 …
GBW DARMSTADT